Placental tissue grafts

US9415074B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9415074-B2
Application numberUS-201514919692-A
CountryUS
Kind codeB2
Filing dateOct 21, 2015
Priority dateSep 7, 2007
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

First claim

Opening claim text (preview).

What is claimed is: 1. A dehydrated, laminated bilayer tissue graft consisting essentially of a) a washed, cleaned and dehydrated amnion layer isolated from a placenta; b) a washed, cleaned and dehydrated chorion layer isolated from a placenta; wherein the amnion layer has a first side which is an exposed basement membrane and a second side which is a fibroblast layer, and further wherein the chorion is in direct contact with the amnion and the two layers are laminated together. 2. The dehydrated, laminated tissue graft of claim 1 , wherein the amnion layer and the chorion layer are isolated from the same placenta. 3. The dehydrated, laminated tissue graft of claim 1 , wherein one or both of the amnion layer and the chorion layer are treated with an antibiotic prior to lamination. 4. The dehydrated, laminated tissue graft of claim 1 , wherein the tissue graft has been exposed to sterilizing conditions. 5. A dehydrated, laminated bilayer tissue graft, wherein the tissue graft consists essentially of an amnion layer and a chorion layer, wherein each of the amnion and chorion layers: a) is separated from a placenta to provide separated layers of amnion and chorion; b) is washed and substantially cleaned; and c) is layered directly over the other and heat dehydrated and laminated to provide the dehydrated, laminated bilayer tissue graft; wherein the amnion has a first side which is an exposed basement membrane and a second side which is a fibroblast layer. 6. The dehydrated, laminated tissue graft of claim 5 , wherein at least one of the amnion layer or chorion layer has been chemically decontaminated.

Assignees

Inventors

Classifications

  • Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

  • Platelets; Megacaryocytes · CPC title

  • Methods of surface bonding and/or assembly therefor · CPC title

  • subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9415074B2 cover?
Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the base…
Who is the assignee on this patent?
Mimedx Group Inc
What technology area does this patent fall under?
Primary CPC classification A61L27/3683. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).